Klinikum Oldenburg AöR — Clinical Trial Site

82 Registered trials

39 Currently recruiting

Organisation

Klinikum Oldenburg AöR

Location

Oldenburg, Germany

Identifier

ORG-100024430

Address

Rahel-Straus-Strasse 10, Kreyenbrueck, 26133, Germany

Departments

#1415: Universitätsklinik für Innere Medizin- Kardiologie
2209:Universitaetsklinik für Dermatologie und Allergologi
Abt. Hämatologie / Onkologie
Abt. Onkologie/Hämatologie
Allgemeine Kinderheilkunde, Hämatologie und Onkologie
Autologous Stem Cell Transplantation
Clinic for Dermatology and Allergology
Clinic for Dermatologyand Allergology
Department of Dermatology
Department of Internal Medicine Oncology and Hematology
Department of Internal Medicine - Oncology and Haematology
Dermatologie und Allergologie
Dermatologische Privatambulanz, Studienambulanz, Ambulanz, Tagesklinik und OP
Dermatology
Dermatology and Allergology
Hematology
Innere Medizin - Onkologie und Hämatologie
Innere Medizin & MVZ
Innere Medizin, Onkologie, Hämatologie
Innere Medizin/Hämatologie / Onkologie
Internal Medicine
Kinder-Hämatologie und -Onkologie
Klinik für Dermatologie und Allergologie
Klinik für Innere Medizin, Hämatologie/Onkologie
Klinik für Innere Medizin, Onkologie und Hämatologe
Klinik für Onkologie und Hämatologie
Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH
N/A
Oncology
Onkologie und Haematologie
Onkologie und Hämatologie
Onkologie/Hämatologie
Pädiatrische Hämatologie und Onkologie
Pädiatrische Onkologie und Hämatologie
Paedriatrics, Department of Oncology and Hematology
Pediatric Hematology/Oncology
Pediatrics and adolescent medicine
Universitätsklinik für Anästhesiologie/ Intensivmedizin/Notfallmedizin/Schmerztherapie
Universitätsklinik für Dermatologie und Allergologie
Universitätsklinik für Herzchirurgie
Universitätsklinik für Innere Medizin - Onkologie / Hämatologie
Universitätsklinik für Innere Medizin - Onkologie und Hämatologie
Universitätsklinik für Innere Medizin - Onkologie und Hämatologie
Universitätsklinik für Innere Medizin - Onkologie und Hematologie
Universitätsklinik für Innere Medizin – Onkologie und Hämatologie
Universitätsklinik für Kinder- und Jugendmedizin
Universitätsklinikum für Dermatologie und Allergologie
Universitätsmedizin Oldenburg Universitätsklinik für Innere Medizin -Onkologie und Hämatologie
University Clinic for Internal Medicine – Oncology and Hematology
Zentrum für Kinder- und Jugendmedizin
Zentrum für Kinder- und Jugendmedizin Abt. Hämatologie / Onkologie

Clinical trials at this site (82)

Search interface

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
EffisayilTM ON: A study to test long-term treatment with spesolimab in people with generalized pustular psoriasis who took part in a previou… Ended

2023-509216-28-00 Generalized Pustular Psoriasis 4 2019-05-27
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
Elotuzumab (E) in Combination with Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) versus KRd prior to and following Autologous Stem Cel… Ended

2024-515783-31-00 Newly Diagnosed Multiple Myeloma 5 2018-08-24
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 acute lymphoblastic leukemia in children and adolescent 5 2018-07-15
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended

2024-513070-21-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 4 2018-02-15
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02
B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended

2023-505509-18-00 mature aggressive B-cell lymphoma and leukemia in child 5 2017-07-12
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
To Investigate whether the combination of molidustat and an IDH1 inhibitor (ivosidenib) effectively inhibits leukaemia cells in patients wit… Halted

2024-514051-15-00 Adult patients with relapsed or refractory IDH1-mutated 7 2023-07-10
Axicabtagene Ciloleucel CAR T-Cells in Patients with relapsed or refractory primary mediastinal B-Cell Lymphoma Ended

2024-510972-19-00 Primary mediastinal large B-cell lymphoma (PMBCL) 4 2025-03-13
Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study for Moderate to Severe Plaque Psoriasis to Evaluate Efficac… Ended

2023-508959-39-00 Moderate to Severe Plaque Psoriasis 5 2025-02-20
A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe … Ended

2024-511360-87-00 hidradenitis suppurativa (HS) 5 2024-10-02
A study to test long-term treatment with spesolimab in people with a skin condition disease called hidradenitis suppurativa (HS) who took pa… Ended

2023-508377-82-00 Hidradenitis Suppurativa (HS) 10 2024-06-27
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis Ended

2023-505841-22-00 Moderate to Severe Plaque Psoriasis 5 2024-04-04
A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-S… Ended

2023-505558-16-00 Atopic Dermatitis 5 2023-10-24
A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended

2022-501074-19-00 Hidradenitis suppurativa 10 2023-10-13
A Phase 2 trial to evaluate the efficacy and safety of daxdilimab in participants with primary discoid lupus erythematosus. Ended

2023-509746-35-00 Primary Discoid Lupus Erythematosus 4 2023-05-16
A randomized phase III non-inferiority trial assessing lenalidomide, bortezomib and dexame-thasone induction therapy with either intravenous… Ended

2024-516300-41-00 Multiple Myeloma 5 2023-03-07
Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma af… Ended

2024-510590-14-00 multiple myeloma 5 2023-03-03